Affinity maturation and characterization of the ofatumumab monoclonal antibody-Reference-Cited by-同舟云学术

Affinity maturation and characterization of the ofatumumab monoclonal antibody

Published:2018-08-30 Issue:1 Volume:120 Page:940-950
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Payandeh Zahra¹^ORCID,Rajabibazl Masoumeh²³^ORCID,Mortazavi Yousef¹⁴^ORCID,Rahimpour Azam³^ORCID,Taromchi Amir Hossein¹⁴^ORCID,Dastmalchi Siavoush⁵⁶^ORCID

Affiliation:

1. Department of Medical Biotechnology and Nanotechnology Faculty of Medicine, Zanjan University of Medical Sciences Zanjan Iran

2. Department of Clinical Biochemistry Faculty of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran

3. Department of Tissue Engineering and Applied Cell Sciences School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran

4. Cancer Gene Therapy Research Center, Department of Medical Biotechnology and Nanotechnology Faculty of Medicine, Zanjan University of Medical Sciences Zanjan Iran

5. Biotechnology Research Center, Department of Medicinal chemistry, School of Pharmacy, Tabriz University of Medical Sciences Tabriz Iran

6. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Near East University, Nicosia, North Cyprus Mersin Turkey

Funder

Shahid Beheshti University of Medical Sciences

Zanjan University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27457

Reference34 articles.

1. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns

2. Management of infectious complications in patients with chronic lymphocytic leukemia;Morrison VA;ASH Education Program Book,2007

3. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

4. The biology of CD20 and its potential as a target for mAb therapy. B cell trophic factors and B cell antagonism in autoimmune disease;Cragg MS;Karger Publishers,2004

5. CD20 deficiency in humans results in impaired T cell–independent antibody responses

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Stable CHO-K1 Cell Lines Overexpressing Full-Length Human CD20 Antigen;IRAN BIOMED J;2023

2. Development of Stable CHO-K1 Cell Lines Overexpressing Full Length Human CD20 Antigen;Iranian Biomedical Journal;2023-09-01

3. Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications;Biomedicine & Pharmacotherapy;2023-08

4. An Updated Review on Recent Advances in the Usage of Novel Therapeutic Peptides for Breast Cancer Treatment;International Journal of Peptide Research and Therapeutics;2023-03-02

5. Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid;Cellular & Molecular Biology Letters;2022-09-05